Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BD acquires Accuri Cytometers

This article was originally published in Clinica

Executive Summary

Becton Dickinson has acquired personal flow cytometer developer Accuri Cytometers for an undisclosed sum. Flow cytometry is used to count and examine microscopic particles such as cells and chromosomes, and can be used to help diagnose disorders such as cancers, as well as having applications in other fields including molecular biology and immunology. Accuri (Ann Arbor, Michigan) markets the C6 system, designed to be portable and affordable, but with the capabilities of a conventional flow cytometer. The acquisition will expand Franklin Lakes, New Jersey-based BD's presence in the affordable personal flow cytometer segment, and the firm believes it will make the technique more accessible to a wider range of scientists and clinicians. The financial impact of the buy has already been incorporated into BD's 2011 financial guidance: in February, the firm predicted that revenues will increase by about 4% over fiscal 2010, and it expects earnings of $5.45-5.55 per share, representing an 11-13% year-on-year increase.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT096942

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel